BRMS1L Antikörper (AA 151-246) (Cy7)
Kurzübersicht für BRMS1L Antikörper (AA 151-246) (Cy7) (ABIN730939)
Target
Alle BRMS1L Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 151-246
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human BRMS-1
-
Isotyp
- IgG
-
-
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (AA 151-246) antibody
BRMS1L Reaktivität: Human WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) antibodyBRMS1L Reaktivität: Human, Maus ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (C-Term) antibodyBRMS1L Reaktivität: Human, Maus, Ratte WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (Internal Region) antibodyBRMS1L Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (AA 1-30), (N-Term) antibodyBRMS1L Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB27800 unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (AA 181-230) antibodyBRMS1L Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Schwein, Fledermaus, Huhn, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (C-Term) antibodyBRMS1L Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio), Schwein, Fledermaus, Huhn, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L) (Internal Region) antibodyBRMS1L Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- BRMS1L (Breast Cancer Metastasis-Suppressor 1-Like (BRMS1L))
-
Andere Bezeichnung
- BRMS-1
-
Hintergrund
-
Synonyms: Breast cancer metastasis-suppressor 1, BRMS1
Background: Transcriptional repressor. Down-regulates transcription activation by NF-kappa-B by promoting the deacetylation of RELA at 'Lys-310'. Promotes HDAC1 binding to promoter regions. Down-regulates expression of anti-apoptotic genes that are controlled by NF-kappa-B. Promotes apoptosis in cells that have inadequate adherence to a substrate, a process called anoikis, and may thereby inhibit metastasis. May be a mediator of metastasis suppression in breast carcinoma.
-
Gen-ID
- 25855
-
UniProt
- Q9HCU9
Target
-
